{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/cardio-metabolic-rare-diseases-strategic-insights-country-and-site-distribution#webpage",
"url": "https://www.fortrea.com/insights/cardio-metabolic-rare-diseases-strategic-insights-country-and-site-distribution",
"name": "Cardio-metabolic rare diseases: strategic insights for country and site distribution",
"description": "This Fortrea white paper explores research insights and clinical research challenges associated with cardiometabolic rare diseases and evolving understanding across rare disease research environments. The content focuses on cardiometabolic rare diseases, cardiometabolic disorders, rare disease research insights, evolving clinical understanding, and research considerations affecting studies involving complex and low-prevalence conditions. The white paper highlights challenges related to limited disease awareness, evolving scientific understanding, clinical variability, and difficulties associated with advancing research across cardiometabolic rare disease areas. Fortrea discusses scientific and clinical perspectives designed to support improved understanding of cardiometabolic rare diseases and strengthen research approaches within evolving rare disease environments. By integrating disease insights with rare disease research considerations and clinical understanding strategies, the white paper provides insights into clinical research challenges affecting cardiometabolic rare diseases and broader rare disease research programs."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Cardio-metabolic rare diseases: strategic insights for country and site distribution",
"item": "https://www.fortrea.com/insights/cardio-metabolic-rare-diseases-strategic-insights-country-and-site-distribution"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/cardio-metabolic-rare-diseases-strategic-insights-country-and-site-distribution#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/cardio-metabolic-rare-diseases-strategic-insights-country-and-site-distribution#webpage"
},
"headline": "Cardio-Metabolic Rare Disease Clinical Trial Site & Country Strategy | Fortrea White Paper",
"description": "This Fortrea white paper explores research insights and clinical research challenges associated with cardiometabolic rare diseases and evolving understanding across rare disease research environments. The content focuses on cardiometabolic rare diseases, cardiometabolic disorders, rare disease research insights, evolving clinical understanding, and research considerations affecting studies involving complex and low-prevalence conditions. The white paper highlights challenges related to limited disease awareness, evolving scientific understanding, clinical variability, and difficulties associated with advancing research across cardiometabolic rare disease areas. Fortrea discusses scientific and clinical perspectives designed to support improved understanding of cardiometabolic rare diseases and strengthen research approaches within evolving rare disease environments. By integrating disease insights with rare disease research considerations and clinical understanding strategies, the white paper provides insights into clinical research challenges affecting cardiometabolic rare diseases and broader rare disease research programs.",
"genre": "White Paper",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2024-10-14",
"dateModified": "2024-10-14",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2024-10/WP%200037%20Cardio%20Metabolic%20Rare%20Diseases%20Insights%200923.pdf",
"encodingFormat": "application/pdf"
}
}
]
}